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ABSTRACT: The Brucella abortus vaccine strain RB51 (SRB51) is being considered for use in the
management of brucellosis in wild bison (Bison bison) and elk (Cervus elaphus) populations in the
Greater Yellowstone Area (USA). Evaluation of the vaccine’s safety in non-target species was con-
sidered necessary prior to field use. Between June 1998 and December 1999, ground squirrels
(Spermophilus richardsonii, n 5 21), deer mice (Peromyscus maniculatus, n 5 14), prairie voles
(Microtus ochrogaster, n 5 21), and ravens (Corvus corax, n 5 13) were orally inoculated with
SRB51 or physiologic saline. Oral and rectal swabs and blood samples were collected for bacteri-
ologic evaluation. Rodents were necropsied at 8 to 10 wk and 12 to 21 wk post inoculation (PI),
and ravens at 7 and 11 wk PI. Spleen, liver and reproductive tissues were collected for bacteriologic
and histopathologic evaluation. No differences in clinical signs, appetite, weight loss or gain, or
activity were observed between saline- and SRB51-inoculated animals in all four species. Oral and
rectal swabs from all species were negative throughout the study. In tissues obtained from SRB51-
inoculated animals, the organism was isolated from six of seven (86%) ground squirrels, one of six
(17%) deer mice, none of seven voles, and one of five (20%) ravens necropsied at 8, 8, 10, and 7
wk PI, respectively. Tissues from four of seven (57%) SRB51-inoculated ground squirrels were
culture positive for the organism 12 wk PI; SRB51 was not recovered from deer mice, voles, or
ravens necropsied 12, 21, or 11 wk, respectively, PI. SRB51 was not recovered from saline-inocu-
lated ground squirrels, deer mice, or voles at any time but was recovered from one saline-inoculated
raven at necropsy, 7 wk PI, likely attributable to contact with SRB51-inoculated ravens in an
adjacent aviary room. Spleen was the primary tissue site of colonization in ground squirrels, followed
by the liver and reproductive organs. The results indicate oral exposure to SRB51 does not produce
morbibity or mortality in ravens, ground squirrels, deer mice, or prairie voles.
Key words: biosafety, Brucella abortus, brucellosis, deer mice, ground squirrels, non-targets,
ravens, RB51, voles.
INTRODUCTION
Brucellosis was detected in bison (Bison
bison) of Yellowstone National Park (YNP;
USA) in 1917, when serologic tests re-
vealed Brucella spp. antibodies in two bi-
son cows that had recently aborted (Moh-
ler, 1917). In elk (Cervus elaphus) popu-
lations in YNP, brucellosis was detected as
early as 1930 (Murie, 1951). Infected bi-
son and elk that roam outside of YNP have
the potential to transmit the disease to
brucellosis-free cattle herds in the sur-
rounding Greater Yellowstone Area (GYA).
Because of the brucellosis-free status in
the states of Idaho, Wyoming, and Mon-
tana, there is interest in developing and
implementing an effective disease control
program for Brucella abortus in bison and
elk in the GYA.
Management strategies considered for
the control and eradication of brucellosis
in the GYA include vaccination of wild bi-
son and elk populations. Brucella abortus
strain RB51 (SRB51), a rough, mutant var-
iant of B. abortus strain 2308 (Schurig et
al., 1991), is a vaccine candidate for use in
wildlife. Strain RB51 has been shown to
be efficacious in cattle (Cheville et al.,
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1993), and safe in bison (Elzer et al., 1998;
Olsen et al., 1999) and elk (Cook et al.,
2000; Kreeger et al., 2000). Studies of
SRB51 in elk have failed to demonstrate
efficacy (Cook, 1999; Kreeger et al., 2000;
J.J. Kreeger, unpubl. data); in limited stud-
ies, SRB51 has produced protection in bi-
son (Olsen et al., 2000; S.C. Olsens un-
publ. data).
There is concern about the introduction
of a live vaccine into the GYA and its po-
tential impact on resident animal popula-
tions that include unique genetics and
threatened or endangered species. The
Greater Yellowstone Interagency Brucel-
losis Committee (GYIBC; Boise, Idaho,
USA) a state and federal interagency com-
mittee established to facilitate the devel-
opment and implementation of brucellosis
management plans for elk and bison in the
GYA, has identified several non-target spe-
cies in the GYA in which the safety of any
vaccine candidate should be evaluated.
These species include representative un-
gulates, carnivores, rodents, and birds. In
nature, they would likely be exposed to the
organism via contact with SRB51-contam-
inated material or scavenging on an in-
fected carcass. Several studies evaluating
the safety of SRB51 in non-target ungu-
lates and carnivores have been completed
(T. J. Kreeger, pers. comm.). Additionally,
a study evaluating the safety of SRB51 in
deer mice (Peromyscus maniculatus) has
been reported (Cook et al., 2001). The
purpose of this study was to evaluate the
safety of oral exposure of common ravens
(Corvus corax), deer mice, Richardson’s
ground squirrels (Spermophilus richard-
sonii), and prairie voles (Microtus ochro-
gaster) to SRB51. These species were se-
lected from the list of representative non-
targets developed by the GYIBC.
MATERIALS AND METHODS
Thirteen mature and immature ravens of ei-
ther sex were captured at the Larimer County
Landfill Fort Collins, Colorado (USA; 408309N,
105869W) and housed in pairs in an outdoor
aviary at a Colorado Division of Wildlife facility
(Fort Collins, Colorado) from June 1998 until
November 1998. Twenty-one mature ground
squirrels of either sex captured near Roundup
(Montana, USA; 468279N, 1088289W), 21 ma-
ture deer mice of either sex selected from a
breeding colony located at the National Wild-
life Research Center (NWRC; Fort Collins,
Colorado, USA), and 21 mature prairie voles of
either sex, wild-caught near the NWRC were
maintained individually in the Animal Research
Building (NWRC, Fort Collins, Colorado) from
July 1998 until September 1998, October 1998
until December 1998, and July 1999 until De-
cember 1999, respectively. Ravens were ex-
posed to natural lighting and temperature con-
ditions, and the rodent environment was tem-
perature and light controlled (22 C, 12 hr light-
12 hr darkness cycle). Ravens, ground squirrels,
deer mice, and voles were randomly divided
into SRB51-inoculated (n 5 9, n 5 14, n 5 14,
n 5 14) and control (n 5 4, n 5 7, n 5 7, n 5
7) groups respectively. A commercially avail-
able SRB51 vaccine (Colorado Serum Compa-
ny, Denver, Colorado) was rehydrated accord-
ing to manufacturer’s instructions and diluted
in physiologic saline. SRB51-inoculated deer
mice and voles orally received SRB51 in a 1 ml
volume, whereas SRB51-inoculated ravens and
ground squirrels orally received SRB51 in a
0.25 ml volume. Control animals were given
the same oral volume of physiologic saline. Af-
ter incubation at 37 C with 5% CO2 for 72 hr,
vaccine viability was determined by standard
plate counts on tryptose agar containing 5% bo-
vine serum.
All animals were observed daily. Oral and
rectal swabs were collected from all ravens,
ground squirrels, and deer mice prior to inoc-
ulation and weekly throughout the study. In
voles, swabs were collected 1, 2, 4, 7 and 14
days PI and every 2 wk thereafter. In rodents,
fecal swabs were usually accompanied by one
or two fecal pellets expelled during the swab-
bing process. Collected swabs were stored at
269 C prior to bacteriologic evaluation. Based
on previous rodent studies (Stevens et al.,
1996), control and SRB51-inoculated deer
mice and ground squirrels were randomly se-
lected to be euthanized for necropsy at 8 and
12 wk PI; ravens were necropsied at 7 and 11
wk PI and voles were necropsied at 10 and 21
wk PI. At necropsy, tissues were evaluated for
gross lesions, and spleen, liver, and reproduc-
tive tract (testes, accessory sex glands, uterine
horns and uterus) were collected for bacterio-
logic and histologic evaluation. Additionally,
samples of kidney, heart, and lung were col-
lected for histologic evaluation. Histologic
specimens were placed in 10% neutral buffered
formalin whereas bacteriologic samples were
stored at 269 C until processing. Specimens
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were sent to the National Animal Disease Cen-
ter (Ames, Iowa, USA) for bacteriologic eval-
uation and to the National Veterinary Services
Laboratories (Ames, Iowa) for histologic pro-
cessing.
For bacteriologic evaluation, tissues were
weighted, minced using a tissue grinder, serially
diluted in saline, and placed on a selective me-
dium for SRB51 (Hornsby et al., 2000). Anti-
biotics in the BR132 selective medium mini-
mize growth of contaminants without inhibiting
the growth of SRB51, and thereby enhance the
ability to detect small numbers of SRB51 with-
in samples. Oral and rectal swabs were directly
plated onto BR132 media. After incubation of
plates at 37 C with 5% CO for 72 hr, bacterial
cell counts were made from each dilution by
standard plate counts. Brucella spp. isolates
were identified as strain RB51 based on colony
morphology, growth characteristics (Alton et
al., 1988), rifampin resistance (Schurig et al.,
1991), and a Brucella spp. specific polymerase
chain reaction procedure based on that of
Bricker and Halling (1995). Briefly, the reac-
tion mixture consisted of heat-killed cells, 0.2
mM nucleotide mix (Bochringer Mannheim,
Mannheim, Germany), 1 3 PCR Buffer II
(Perkin Elmer, Branchburg, New Jersey,
USA), 2.5 U/ml DNA polymerase (Amplitaq
Gold, Perkin Elmer, Branchburg, new Jersey),
and 1.5 mM MgCl combined with 20 pm per
reaction of specific primers for B. abortus
omp2A as selected from analysis of its se-
quence (Ficht et al., 1989) (upstream primer
GCAACGGTGTTCTTCCACTC and down-
stream primer GTATCAGGCTACGCAGAA-
GG). The samples, including positive and neg-
ative controls, were cycled (30 sec 95C, 30 sec
44C, 1 min 72C) 30 times in a thermocycler
(MJ Research Inc., Watertown, Massachusetts,
USA). Products (5 to 8:1 from each reaction
mixture) were separated by electrophoresis on
a 1.5% agarose gel and analyzed after staining
with ethidium bromide.
Formalin-fixed tissues were embedded in
paraffin, sectioned at a thickness of 5 mm, and
stained with hematoxylin and eosin for light mi-
croscopic examination. Spleens and reproduc-
tive tracts from deer mice and voles were not
collected for histopathology. Assessment of
morbidity was based on results of visual and
physical examination, including weight gain/
loss, evaluation of ocular and nasal secretions,
lethargy, fecal characteristics, feed intake, and
coat/feather appearance.
RESULTS
Standard plate counts indicated that
SRB51-inoculated ravens, ground squir-
rels, deer mice, and voles received 1.5 3
108, 7.8 3 107, 4.5 3 107, and 1.6 3 109
colony forming units (CFU) of SRB51, re-
spectively.
Two ravens died during the study. The
first died during the acclimation period
prior to vaccination; the second raven died
2 wk post-vaccination after exhibiting re-
spiratory distress of several days duration.
The cause of the first raven’s death was not
apparent. Lesions in the second raven in-
dicated mycotic pneumonia and serositis.
One SRB51-inoculated mouse died im-
mediately after inoculation and one con-
trol mouse died at 4 days PI. Deaths were
attributed to handling and probable aspi-
ration of the inoculum. One control vole
died at 7 wk PI; the cause of death was
undetermined.
Bacteriologic cultures of oral and rectal
swabs from all species were negative for
recovery of SRB51. All tissues collected
from voles at necropsy 10 or 21 wk PI
were negative for brucellae. SRB51 was
isolated from tissues collected at necropsy
from one deer mouse, and ten ground
squirrels. Two ravens, including one in the
control group, were also culture-positive
for SRB51 (Table 1, 2). Colony counts var-
ied from 1.0 colony forming units (CFU)/
g of tissue cultured to 8.0 3 104 CFU/g.
Tissues evaluated from remaining test an-
imals were culture-negative for SRB51.
Gross lesions consisted of splenomegaly
and petechiation of the liver and testes in
one SRB51-inoculated ground squirrel
(CH23). Microscopic examination of tissue
sections from ravens, deer mice, and voles
revealed no difference between SRB51-in-
oculated and control animals. Livers of six
of the 10 culture-positive ground squirrels
contained small to moderate focal granu-
lomas randomly located in the hepatic pa-
renchyma. The granulomas consisted of
small and large mononuclear cells and rare
multinucleated cells. The granulomas were
often accompanied by focal necrosis and/
or increased periportal lymphoplasmacytic
infiltrates. One SRB51-inoculated vole
necropsied at 10 wk had a disseminated
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TABLE 1. Burella abortus SRB51 culture results (colony forming units (CFU)/g tissue cultured) on tissues
from culture-positive ravens, deer mice and ground squirrels.
Species Animal IDa
Necropsy
(Wk PI) Liver Spleen
Reproductive
tract
Common raven
Common raven
Deer mouse
Ground squirrel
Ground squirrel
Ground squirrel
Ground squirrel
Ground squirrel
Ground squirrel
Ground squirrel
Ground squirrel
Ground squirrel
Ground squirrel
803-T
805-C
BZ 13-T
CH 12-T
CH 13-T
CH 15-T
CH 17-T
CH 18-T
CH 22-T
CH 23-T
CH 25-T
CH 28-T
CH 29-T
7
7
8
8
8
8
8
8
8
12
12
12
12
2b
2
11
2
2
1
11
2
2
111
1
2
11
2
111
11
11
1
111
1111
1111
1
1111
1111
111
1111
1
2
1
2
2
2
1
2
2
1
2
2
2
a T 5 SRB51-inoculated; C 5 Saline inoculated.
b 2 5 culture-negative for SRB51; 1 5 ,100 colony forming units (CFU)/g; 11 5 100–999 CFU/g; 111 5 1000-10,000
CFU/g; 1111 5 . 10,000 CFU/g.
TABLE 2. Brucella abortus SRB51 culture-positive
animals per total number animals in group necrop-
sied.
Species
First
groupa
controls
First
group
vacci-
nates
Second
groupb
controls
Second
group
vacci-
nates
Common raven
Deer mouse
Ground squirrel
Prairie vole
1/2
0/3
0/4
0/3
1/5
1/6
6/7
0/7
0/2
0/3
0/3
0/3
0/5
0/7
4/7
0/7
a First group was necropsied at 7 wk PI (common ravens), 8
week PI (deer mice and ground squirrels) and 10 wk PI
(prairie voles).
b Second group was necropsied at 11 wk PI (common ra-
vens), 12 wk PI (deer mice and ground squirrels), and 21
week PI (prairie voles).
histiocytic pneumonia and lymphoplasma-
cytic myocarditis of undetermined origin.
No lesions were noted in tissues from oth-
er animals.
No differences in clinical signs, appetite,
weight grain or loss, or activity were ob-
served between control and SRB51-inoc-
ulated animals in all four species.
DISCUSSION
The negative culture results of the oral
and rectal swabs indicate a lack of persis-
tent shedding of the SRB51 organism by
any of the species tested. The SRB51 or-
ganism may have been shed by ravens,
ground squirrels, and deer mice during the
first few days PI and was therefore not de-
tected as the first PI swabs were collected
at one wk PI. Surprisingly, the modified
collection protocol that was designed to
detect early shedding in the voles did not
result in positive cultures. The limited sen-
sitivity of direct plating of fecal swabs may
not have allowed the detection of fecal
shedding of low numbers of SRB51 organ-
isms.
The cause of SRB51 infection in the
control raven is undetermined. The organ-
ism may have been transferred to the bird
via direct contact as the infected control
raven was in an aviary room adjacent to
the SRB51-inoculated ravens; a small area
of the separating wall consisted of woven
wire. Alternatively, the organism could
have been transferred via contaminated
clothing, feed bowls, or capture nets and
drapes, or conceivably by wild deer mice
which frequented the outdoor aviary.
Tissue colonization of SRB51 appears to
persist in ground squirrels for a greater pe-
riod of time than in the ravens, deer mice,
and voles. However, the SRB51 organism
536 JOURNAL OF WILDLIFE DISEASES, VOL. 37, NO. 3, JULY 2001
did not produce any clinical signs of illness
in any of the species studied. Clearance of
SRB51 by 12 wk in the deer mice and by
10 wk in the voles is consistent with results
from previous studies in mice. In one
study, BALB/c mice infected with 5 3 107
CFU of SRB51 intraperitoneally (IP)
cleared the infection between 30 and 60
days PI, whereas those infected with 1 3
104 CFU of virulent B. abortus strain 2308
harbored the bacteria through 60 days PI
(Palmer et al., 1996). In another study
BALB/c mice showed clearance of 9.2 3
106 CFU of SRB51 from spleens in ,6 wk
and persistance of 1.2 3 105 CFU of strain
2308 for .20 wk (Stevens et al., 1994). In
a third mouse study, SRB51 antigen per-
sisted for 4 wk in parotid lymph nodes af-
ter oral inoculation with 5 3 108 CFU, but
the organism was not recovered from the
spleen between 2 and 12 wk PI. (Stevens
et al., 1996) In a recent deer mouse study,
orally inoculated mice receiving 1 3 108
CFU SRB51 cleared the infection by 6 wk
and mice receiving a similar inoculum IP
cleared the infection by 9 wk (Cook et al.,
2001) Granulomas similar to those noted
in the ground squirrel livers have been ob-
served in B. abortus strain 19- inoculated
BALB/c mice (Enright et al., 1990) and
Brucella suis biovar 4-inoculated ground
squirrels (Citellus parryii) (Miller et al.,
1980).
In summary, oral exposure to SRB51 did
not produce observed morbidity or mor-
tality in ravens, ground squirrels, deer
mice, or prairie voles. Neither fecal nor
oral shedding was detected. Ravens, deer
mice, and voles cleared the infection by 8
to 10 wk. However, SRB51 infection per-
sisted in some ground squirrels for at least
12 wk. Further investigation to determine
the duration of SRB51 infection in ground
squirrels is merited.
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